Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Professor of Practice (Paediatric Cardiology)



+44 (0)20 7351 8430p.daubeney




Royal BromptonRoyal Brompton Campus





Dr Piers Daubeney is Reader in Paediatric Cardiology at NHLI, Imperial College London and Consultant Paediatric and Fetal Cardiologist at the Royal Brompton Hospital, Chelsea and Westminster Hospital and 3 district hospitals in the South-East.

He trained at Oxford and St Thomas' Hospitals with postgraduate training at the Wessex Cardiovascular Centre in Southampton, Royal Children's Hospital, Melbourne and the Hospital for Sick Children, Toronto.

Dr Daubeney has a research team and particular interests in the epidemiology and management of congenital heart disease, childhood cardiomyopathy, and drug studies in paediatric heart disease. He has jointly founded the following ongoing international multi-centre studies:

  • UK and Ireland Study of Pulmonary Atresia with Intact Ventricular Septum
  • National Australian Childhood Cardiomyopathy Study
  • UK, Ireland and Sweden Study of Total Anomalous Pulmonary Venous Connection
  • UK, Ireland and Sweden Study of Pulmonary Vein Stenosis.

He is also interested in the mechanisms of congenital heart disease and in particular connexin expression. He participates in a number of paediatric multi-centre drug trials in congenital heart disease.

Dr Daubeney has published widely in the field of congenital heart disease and his textbook ‘Diagnosis and Management of Adult Congenital Heart Disease' jointly edited with Professors Gatzoulis and Webb, is now in its third edition having been translated into several different languages.

Dr Daubeney is the lead clinician for paediatric cardiomyopathy at the Royal Brompton Hospital and has an active research programme. He welcomes postgraduate research fellows intending to attain higher qualifications.



Krupickova S, Voges I, Mohiaddin R, et al., 2023, Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer/BioNTech vaccine-related myocarditis in adolescents, Pediatric Radiology, Vol:53, ISSN:0301-0449, Pages:892-899

Voges I, Caliebe A, Hinz S, et al., 2023, Pediatric Cardiac Magnetic Resonance Reference Values for Biventricular Volumes Derived From Different Contouring Techniques, Journal of Magnetic Resonance Imaging, Vol:57, ISSN:1053-1807, Pages:774-788

Norrish G, Kolt G, Cervi E, et al., 2022, Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study, Esc Heart Failure, Vol:8, ISSN:2055-5822, Pages:5057-5067

Voges I, Negwer I, Caliebe A, et al., 2022, Myocardial Deformation in the Pediatric Age Group: Normal Values for Strain and Strain Rate Using 2D Magnetic Resonance Feature Tracking, Journal of Magnetic Resonance Imaging, Vol:56, ISSN:1053-1807, Pages:1382-1392

Voges I, Caliebe A, Hinz S, et al., 2022, Reference Values for Pediatric Atrial Volumes Assessed by Steady-State Free-Precession Magnetic Resonance Imaging Using Monoplane and Biplane Area-Length Methods, Journal of Magnetic Resonance Imaging, ISSN:1053-1807

More Publications